Important triad in cardiovascular medicine - Diabetes, coronary intervention, and platelet glycoprotein IIb/IIIa receptor blockade

被引：54

作者：

Lincoff, AM ^{[1
]}

机构：

[1] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA

来源：

CIRCULATION | 2003年 / 107卷 / 11期

关键词：

D O I：

10.1161/01.CIR.0000055653.52489.E9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1556 / 1559

页数：4

共 33 条

[1] Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients - Insights from the Arterial Revascularization Therapy Study (ARTS) trial [J].

Abizaid, A ;

Costa, MA ;

Centemero, M ;

Abizaid, AS ;

Legrand, VMG ;

Limet, RV ;

Schuler, G ;

Mohr, FW ;

Lindeboom, W ;

Sousa, AGMR ;

Sousa, JE ;

van Hout, B ;

Hugenholtz, PG ;

Unger, F ;

Serruys, PW .

CIRCULATION, 2001, 104 (05) :533-538

[2] The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation [J].

Abizaid, A ;

Kornowski, R ;

Mintz, GS ;

Hong, MK ;

Abizaid, AS ;

Mehran, R ;

Pichard, AD ;

Kent, KM ;

Satler, LF ;

Wu, HS ;

Popma, JJ ;

Leon, MB .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (03) :584-589

[3]

Alderman EL, 1996, NEW ENGL J MED, V335, P217

[4] Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention [J].

Anderson, KM ;

Califf, RM ;

Stone, GW ;

Neumann, FJ ;

Montalescot, G ;

Miller, DP ;

Ferguson, JJ ;

Willerson, JT ;

Weisman, HF ;

Topol, EJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (08) :2059-2065

[5] Potential mechanisms promoting restenosis in diabetic patients [J].

Aronson, D ;

Bloomgarden, Z ;

Rayfield, EJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (03) :528-535

[6] Abciximab reduces mortality in diabetics following percutaneous coronary intervention [J].

Bhatt, DL ;

Marso, SP ;

Lincoff, AM ;

Wolski, KE ;

Ellis, SG ;

Topol, EJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (04) :922-928

[7] USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY [J].

CALIFF, RM ;

SHADOFF, N ;

VALETT, N ;

BATES, E ;

GALEANA, A ;

KNOPF, W ;

SHAFTEL, J ;

BENDER, MJ ;

AVERSANO, T ;

RAQUENO, J ;

GURBEL, P ;

COWFER, J ;

COHEN, M ;

CROSS, P ;

BITTL, J ;

EDDINGS, K ;

TAYLOR, M ;

DEROSA, K ;

HATTEL, L ;

COOPER, L ;

ESHELMAN, B ;

FINTEL, D ;

NIEMYSKI, P ;

KLEIN, L ;

KENNEDY, H ;

THORNTON, T ;

KEREIAKES, D ;

MARTIN, L ;

ANDERSON, L ;

HIGBY, N ;

ELLIS, S ;

BREZINA, K ;

GEORGE, B ;

CHAPEKIS, A ;

SMITH, D ;

ANWAR, A ;

GERBER, TL ;

PRITCHARD, GL ;

MYLER, R ;

SHAW, R ;

MURPHY, M ;

WARD, K ;

MADIGAN, NP ;

BLANKENSHIP, J ;

HALBERT, M ;

FLANAGAN, C ;

TANNENBAUM, M ;

POLICH, M ;

STEVENSON, C ;

TCHENG, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :956-961

[8] Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement [J].

Elezi, S ;

Kastrati, A ;

Pache, J ;

Wehinger, A ;

Hadamitzky, M ;

Dirschinger, J ;

Neumann, FJ ;

Schömig, A .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (07) :1866-1873

[9] Management of coronary artery disease: Therapeutic options in patients with diabetes [J].

Hammoud, T ;

Tanguay, JF ;

Bourassa, MG .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (02) :355-365

[10] Mortality and morbidity in diabetic and nondiabetic patients during a 2-year period after coronary artery bypass grafting [J].

Herlitz, J ;

Wognsen, GB ;

Emanuelsson, H ;

Haglid, M ;

Karlson, BW ;

Karlsson, T ;

Albertsson, P ;

Westberg, S .

DIABETES CARE, 1996, 19 (07) :698-703

← 1 2 3 4 →